Table 2.
Pre-pandemic n = 352 |
Pandemic n = 351 |
p value | |
---|---|---|---|
HLOS, median (IQR) | 5 (4, 6) | 5 (3, 6) | 0.45 |
Total ventilator daysa, median (IQR) | 2 (2, 9) | 3 (2, 4) | 0.86 |
Complications | |||
Myocardial infarction | 0.6% (2) | 0.6% (2) | > 0.99 |
Stroke or CVA | 1.7% (6) | 0.6% (2) | 0.29 |
Pulmonary embolism | 0.6% (2) | 0% (0) | 0.50 |
Deep vein thrombosis | 1.1% (4) | 0.9% (3) | > 0.99 |
Discharge disposition, % (n) | |||
Home/home health | 6.5% (23) | 9.4% (33) | 0.16 |
SNF | 24.7% (87) | 18.8% (66) | 0.06 |
LTAC | 10.5% (37) | 6.6% (23) | 0.06 |
Rehabilitation | 11.1% (39) | 11.4% (40) | 0.89 |
Hospice | 2.3% (8) | 4.6% (16) | 0.10 |
Other | 0.3% (1) | 0.9% (3) | 0.37 |
In-hospital mortality, % (n) | 1.1% (4) | 3.4% (12) | 0.04 |
HLOS hospital length of stay, SNF skilled nursing facility, Home/Home health home or home with health care services
aAmong patients ventilated